Home › Research › Topics › brexpiprazole
brexpiprazole
1 study tagged brexpiprazole, dated 2019-10-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
1 studies carry this tag.
Date range
2019
Top journals
- The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
In Study 1, brexpiprazole 2 mg/day demonstrated statistically significantly greater improvement in CMAI Total score from baseline to Week 12 than placebo (adjusted mean difference, -3.77; confidence limits, -7.38, -0.17; t (316) = -2.06; p = 0.040; MMRM).